MR Spectroscopy Identifies Breast Cancer, Reduces Biopsies

Proton magnetic resonance spectroscopy (¹H MRS) used
in conjunction with magnetic resonance imaging (MRI)
can aid the radiologists in diagnosing cancerous breasts
while reducing the number of false-positive results and
invasive biopsies, according to a study focusing
on non-mass enhancing breast lesions.

The study, conducted at Memorial Sloan-Kettering Cancer
Center in New York City, appears in the October issue
of the journal Radiology.

"All of the cancers present in this study were
identified with MR spectroscopy," said the study's
lead author, Lia Bartella, M.D., director of breast
imaging at Eastside Diagnostic Imaging in
New York City.

The American Cancer Society estimates that 212,920
women will be diagnosed with breast cancer in the
United States this year. MRI is playing an increasingly
important role in the screening of women at high risk
for breast cancer. However, while MRI depicts more
abnormal findings than other breast screening procedures,
it is not 100 percent accurate in distinguishing benign
from malignant lesions, resulting in a large number of
breast biopsy procedures recommended on the basis of
imaging findings that are NOT necessary and can lead
to the release of acids that can spoil healthy breast
tissue.

According to Dr. Robert O. Young, a research scientist.
states, "the only difference between a malignant or
benign lesion or tumor is the stage in which the body
is attempting to encapsulate and wall of the acidic
spoiling breast cells from the healthy breast cells.
Given the fact that the end stage of a tumor is to
encapsulate fermenting acidic cells, crystallize and
harden and then break-up."

Currently, approximately 80 percent of breast lesions
biopsied are found to be benign or crystallized breast
cells.

Non-mass enhancing acidic lesions are characterized
by enhancement of an area that is not a mass or lump
and may extend over large or small regions. Non-mass
acidic lesions occur with benign acidic hormonal changes,
but can also signify malignancy. Biopsy is recommended by
current savants to distinguish benign non-mass lesions
from cancerous cells but is not necessary and can
damage healthy breast cells.

With MR spectroscopy, which adds only 10 minutes to a
standard MRI exam, the radiologist is able to see the
chemical make-up of a tumor which contains the acidic
spoiled breast cells. In most cases, the results indicate
whether or not the lesion is cancerous without the need
for biopsy. This is a good thing!

"Non-mass enhancing lesions frequently pose a dilemma
to the radiologist when evaluating the breast for the
presence of cancer, especially in premenopausal women,
" Dr. Bartella said. "Potentially, the use of proton
MRI spectroscopy may help decrease the number of benign
biopsies for non-mass enhancing lesions."

"An immediate shift to an alkaline lifestyle and diet
will show dramatic improvement in the non-mass lesions
within 30 days", stated Dr. Young.

For the study, Bartella and colleagues performed ¹H MRS
on 32 non-mass enhancing breast lesions in 32 women,
ages 20 to 63. Twenty-five of the patients had lesions
that had been labeled suspicious at MRI.

¹H MRS can provide radiologists with chemical
information about an acidic lesion by measuring
the levels of choline compounds, which are
markers of fermenting acidic cells being encapsulated
by fibrin monomers which forms the basis of the tumor.

"The body forms tumors to protect the healthy breast
tissue from being spoiled by the acids from
fermenting cells spoiled by dietary and/or
metabolic acids," states Dr. Young.

In the study, positive choline findings were present
in 15 of 32 lesions, including all 12 cancers, giving
¹H MRS a specificity of 85 percent and a sensitivity
of 100 percent. If only the lesions with positive
choline findings had been biopsied, 17 (68 percent) of
25 lesions may have been spared invasive biopsies and
none of the cancerous tissues would have been missed.

"By performing MR spectroscopy of the suspicious lesion
after an MRI scan, we can noninvasively see which tumors
show elevated choline levels and are likely malignant,"
Bartella said. "This chemical information added to
the information provided by MRI can eliminate the need
for biopsy to find out what the lesion is made of."

According to Dr. Young another means to determine the
state or nature of the non-mass lesions in the breast
tissue is to do an non-invasive live and dried blood
microscopy evaluation.

Bartella hopes that in the future, MR spectroscopy will
be incorporated into routine diagnostic breast MRI
procedures, significantly decreasing the need for
needle biopsies.

Young's hope is that people will come to the realization
that the cure for breast cancer will not be found in
its treatment but will be found in its prevention with
an alkaline lifestyle and diet.

According to Dr. Young, "healthy breasts are alkaline
breasts. Breasts that are acidic contain micro-
calcifications of acids, acidic breast cells,
fibroytic tissue which leads to the formation
of tumors which are only formed to protect the
surrounding healthy tissue."

"It is true that the body will park its dietary and
metabolic acidic waste products in the breast tissue
if they are not eliminated through urination,
defecation, perspiration and respiration."

"If you want to be healthy, vibrant and energetic
free from the risk of cancers cells and tissues
you need to pee and sweat your way there."

To learn more about the science of Dr. Robert
and Shelley Young go to:

www.phmiracleliving.com

To become part of our alkaline community free of
all sickness and disease go to:

www.phmiracleliving.com

Copyright: All rights reserved by Dr. Robert O. Young

pH Miracle Living Center

16390 Dia Del Sol
Valley Center, California
92082
US